01 1Chattem Chemicals, Inc.
02 1SpecGx LLC
01 1Dihydrocodeine Bitartrate
02 1dihydrocodeine bitartrate
01 1Ireland
02 1U.S.A
NDC Package Code : 61960-0100
Start Marketing Date : 2018-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-1578
Start Marketing Date : 2013-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Dihidrocodeina manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihidrocodeina, including repackagers and relabelers. The FDA regulates Dihidrocodeina manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihidrocodeina API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihidrocodeina manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihidrocodeina supplier is an individual or a company that provides Dihidrocodeina active pharmaceutical ingredient (API) or Dihidrocodeina finished formulations upon request. The Dihidrocodeina suppliers may include Dihidrocodeina API manufacturers, exporters, distributors and traders.
click here to find a list of Dihidrocodeina suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dihidrocodeina as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dihidrocodeina API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dihidrocodeina as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dihidrocodeina and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dihidrocodeina NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dihidrocodeina suppliers with NDC on PharmaCompass.
We have 2 companies offering Dihidrocodeina
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
